Tuesday, April 12, 2011

Medical Affairs Executive Forum

Medical Affairs Executive Forum
April 14-15
Basking Ridge, NJ

High-Level Strategies for Managing and Executing Practice Issues and Challenges

Featured Presentations Addressing:
  • Medical Affairs in Today’s Environment
  • Demonstrating Medical Affairs Value
  • REMS Programs
  • Aligning Medical Affairs and Marketing
  • The Current and Future Role of Registries
  • Effectively Communicating Safety Risk Information
  • Future Role of MSD/MSLs
  • Publication Planning Update for Medical Affairs
  • Medical Device Issues and Challenges



Why You Should Attend:
  1. Dedicated to Medical Affairs: There seem to be conferences for everyone in the industry and now ExL presents the only conference dedicated to the addressing the issues, challenges, and concerns of medical affairs professionals
  2. Executive-Level Faculty: Hear from senior level executives with valuable experience to share representing Pharma, Biotech and Device companies including Auxilium, Avanir, Bayer, Boehringer-Ingelheim, Bristol-Myers, Centocor Ortho-Biotech, Cephalon, Daiichi-Sankyo, Eli Lilly, Intermune, Genyzme, J&J, Otsuka, RS Medical, Talecris, Vertex and more!
  3. Expanded Networking: Tri-Located with ExL’s 8th MSL Best Practices and the 13th Investigator-Initiated Trials Conference you will triple your networking opportunities and discuss common challenges and solutions during shared breaks, lunches, roundtable discussions and cocktail reception.
  4. Topics: ExL offers relevant and forward-looking education through highly researched and targeted topics that will meet and exceed your informational needs without the sales pitches
  5. Time and Place: Medical Affairs, MSL, Investigator-Initiated Trials, Medical Education, Medical Communication, Medical Directors, R&D, Scientific Affairs and many other colleagues will be congregating at the Dolce Basking Ridge, New Jersey in the Spring of 2011
Some of the physician faculty members include:

Alan H. Cohen, MD, FAAP, FCCP, FAAAAI, FACAAI
SVP, Medical Affairs
INTERMUNE

Shahin Gharakhanian, MD, DPH
VP, Strategic Medical Education & Publications, Dept. of Medical Affairs, Medicines Development Group (MDG) Global R&D
VERTEX PHARMACEUTICALS

Randall Kaye, MD
Chief Medical Officer
AVANIR PHARMACEUTICALS

Charles Laudadio, MD, MBA
Former Global Medical Affairs Director
CSL BEHRING

Michael Montgomery, MD, CPI
President, Investigator Initiated/Sponsored Research Association (IISRA), Director, Worldwide Medical Affairs, Immunology Research
CENTOCOR ORTHO-BIOTECH, INC, USA

Suku Nagendran, MD
Executive Medical Director, Multi TA Head, Medical Affair
DAIICHI SANKYO

Leo Plouffe, MD, CM, FACOG
Vice President, Medical Affairs, Women’s Healthcare
BAYER

Dominic J. F. Tong, MD
VP, Medical and Clinical Affairs
RS MEDICAL

Radhika Tripuraneni, MD MPH
Global Medical Director - Gaucher & MPS Disease, Global Medical Affairs
GENZYME CORPORATION


ExL Pharma, a division of ExL Events, Inc., is an industry leader in developing innovative, educational conferences that serve the pharmaceutical and allied healthcare communities in the United States, Europe and Latin America. Behind our diverse pharmaceutical event portfolio, our experienced team conducts extensive market research and targeted outreach. The results translate into innovative, high-quality events designed to exceed the dynamic informational and networking needs of specific audiences and working groups.

Learn more about this conference here.

No comments:

Post a Comment

Blog Widget by LinkWithin